Area of research
Oncology · Otorhinolaryngology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Head and Neck Cancer Studies, Bladder and Urothelial Cancer Treatments, and Gastric Cancer Management and Outcomes.
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
LBA2 Perioperative (periop) enfortumab vedotin (EV) plus pembrolizumab (pembro) in participants (pts) with muscle-invasive bladder cancer (MIBC) who are cisplatin-ineligible: The phase III KEYNOTE-905 study
Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer
Enfortumab vedotin in the previously treated advanced head and neck cancer (HNC) cohort of EV-202.
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial
Human Gut Microbiota and Gastrointestinal Cancer
Genetic analysis in a patient with nine primary malignant neoplasms: A rare case of Li-Fraumeni syndrome